Soros Fund Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-150,000
| Closed | -$1.7M | – | 243 |
|
|
2025
Q1 | $1.7M | Sell |
150,000
-325,114
| -68% | -$3.67M | 0.03% | 174 |
|
|
2024
Q4 | $4.99M | Buy |
475,114
+114
| +0% | +$1.2K | 0.08% | 143 |
|
|
2024
Q3 | $4.96M | Hold |
475,000
| – | – | 0.07% | 121 |
|
|
2024
Q2 | $4.85M | Hold |
475,000
| – | – | 0.09% | 121 |
|
|
2024
Q1 | $4.94M | Buy |
+475,000
| New | +$4.94M | 0.08% | 119 |
|